Analysts Set Allogene Therapeutics, Inc. (NASDAQ:ALLO) PT at $9.95
Shares of Allogene Therapeutics, Inc. (NASDAQ:ALLO – Get Free Report) have earned a consensus recommendation of “Moderate Buy” from the ten research firms that are currently covering the firm, Marketbeat Ratings reports. One analyst has rated the stock with a hold rating and nine have issued a buy rating on the company. The average twelve-month […]
Shares of Allogene Therapeutics, Inc. (NASDAQ:ALLO – Get Free Report) have earned a consensus recommendation of “Moderate Buy” from the ten research firms that are currently covering the firm, Marketbeat Ratings reports. One analyst has rated the stock with a hold rating and nine have issued a buy rating on the company. The average twelve-month […]
